Predictors for the Efficacy of Peripheral Blood Progenitor Cell (PBPC) Collection–Results from 4050 Harvests Performed in a Single Centre
Kristina Hoelig(Technische Universität Dresden), Gerhard Ehninger(University Hospital Carl Gustav Carus), Kristin Zimmer, Uta Oelschlaegel(University Hospital Carl Gustav Carus), Martin Bornhaeuser(German Cancer Research Center), Frank Kroschinsky(University Hospital Carl Gustav Carus), Matthias Blechschmidt, Claudia Rutt, Michael Krämer(University Hospital Carl Gustav Carus)
Cited by 1
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402